Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)

被引：0
|
作者：
Cole, Frances M. [1 ]
Laszlo, George S. [2 ]
Lunn-Halbert, Margaret C. [1 ]
Kehret, Allie R. [1 ]
Zweidler-McKay, Patrick A. [3 ]
Rodriguez-Arboli, Eduardo [1 ,4 ]
Wu, David [5 ]
Nyberg, Kyle E. [1 ]
Li, Junyang [1 ]
Lim, Sheryl Y. T. [1 ]
Lakshmikanthan, Sribalaji [3 ]
Walter, Roland B. [6 ,7 ,8 ]
机构：
[1] Fred Hutchinson Canc Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, 1100 Fairview Ave North, Seattle, WA USA
[3] ImmunoGen Inc, Waltham, MA USA
[4] Univ Seville, Hosp Univ Virgen del Rocio, Dept Hematol, Inst Biomed Sevilla, Seville, Spain
[5] Univ Washington, Hematopathol, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Seattle, WA USA
[7] Univ Washington, Dept Med, Div Hematol & Oncol, Seattle, WA USA
[8] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-200907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2751 / 2751
页数：1
相关论文
共 50 条
  • [41] Venetoclax Synergizes with IMGN632, a Novel CD123-Targeting Antibody Conjugated to a DNA Alkylating Payload, By Suppressing DNA Damage Response and Potentiating Apoptosis in Acute Myeloid Leukemia in Vitro Models
    Skwarska, Anna
    Kuruvilla, Vinitha Mary
    Zhang, Qi
    Chaudhry, Sovira
    Daver, Naval
    Watkins, Krystal
    Sloss, Callum Mortimer
    Zweidler-McKay, Patrick A.
    Sampath, Deepa
    Konopleva, Marina Y.
    BLOOD, 2023, 142
  • [42] SGN-CD123A, a Pyrrolobenzodiazepine Dimer Linked Anti-CD123 Antibody Drug Conjugate, Demonstrates Effective Anti-Leukemic Activity in Multiple Preclinical Models of AML
    Sutherland, May S. K.
    Yu, Changpu
    Walter, Roland B.
    Westendorf, Lori
    Valliere-Douglass, John
    Pan, Lucy
    Sussman, Django
    Anderson, Martha
    Zeng, Weiping
    Stone, Ivan
    Klussman, Kerry
    Ulrich, Michelle
    Jonas, Mechthild
    Senter, Peter
    Drachman, Jonathan G.
    Benjamin, Dennis
    BLOOD, 2015, 126 (23)
  • [43] Preclinical characterization of STRO-002, a clinical-stage anti-FolRa antibody-drug conjugate
    Yuan, Robert
    McGeehan, Andrew
    Zhou, Sihong
    Smith, Jennifer
    Moreira, Dayson
    Bajjuri, Krishna
    Cuong Tran
    Yin, Gang
    Yam, Alice
    Kiefel, Helena
    Li, Xiaofan
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [44] VIP943 Is a Novel CD123 Antibody Drug Conjugate with in Vitro and In Vivo Efficacy in Acute Myeloid Leukemia (AML) Models
    Stelte-Ludwig, Beatrix
    Clemens, George
    Schomber, Tibor
    Frigault, Melanie M.
    Johnson, Amy J.
    Lerchen, Hans-Georg
    Izumi, Raquel
    Hamdy, Ahmed
    BLOOD, 2022, 140 : 5955 - 5956
  • [45] Preclinical development and characterization of STI-6129, an anti-CD38 antibody-drug conjugate, as a new therapeutic agent for multiple myeloma
    Li, Lingna
    Hau, Andrew
    Tong, Wenyong
    Lau, Megan
    Zhu, Tong
    Fells, Katherine
    Wei, Angel
    Li, Xiaoqing
    Deng, Dylan
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Yan, Zheng
    Zhu, Panyun
    Zhou, Heyue
    Ji, Henry
    Li, Hui
    Zhang, Hong
    CANCER RESEARCH, 2020, 80 (16)
  • [46] IMGN632, a CD123-Alkylating ADC Bearing a DNA-Alkylating IGN Payload, Combines Effectively with Azacitidine and Venetoclax In Vivo, Prolonging Survival in Preclinical Models of Human Acute Myeloid Leukemia (AML)
    Kuruvilla, Vinitha Mary
    McCarthy, Rebecca
    Zhang, Qi
    Sloss, Callum M.
    Zweidler-McKay, Patrick A.
    Romanelli, Angela
    Adams, Sharlene
    Konopleva, Marina Y.
    BLOOD, 2019, 134
  • [47] Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate
    Tuereci, Oezlem
    Kreuzberg, Maria
    Walter, Korden
    Woell, Stefan
    Schmitt, Ramona
    Yamada, Tomohiro
    Nakajo, Ikumi
    Sahin, Ugur
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Antitumor effect of IMGN289, an anti-EGFR antibody-drug conjugate (ADC), in preclinical models of head and neck squamous cell carcinomas (HNSCC)
    Kang, Hyunseok
    Thakar, Manjusha
    Sen, Rupashree
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission
    L H Xie
    M Biondo
    S J Busfield
    A Arruda
    X Yang
    G Vairo
    M D Minden
    Blood Cancer Journal, 2017, 7 : e567 - e567
  • [50] Preclinical Characterization of XB002, an Anti-Tissue Factor Antibody-Drug Conjugate for the Treatment of Solid Tumors
    Kantak, Seema
    Faggioni, Raffaella
    Cai, Allen G.
    Bhatti, Maryam M.
    Li, Jing
    Vainshtein, Inna
    Cheng, Jackie
    Mendelsohn, Brian A.
    Gaudreault, Jacques
    Migone, Thi-Sau
    Theunissen, Jan-Willem
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (02) : 251 - 260
12345